Koers Biotie Therapies Corp

Aandelen

Vertraagde tijd Nasdaq Helsinki Andere beurzen			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
- ^EUR	-.--%		-.--%	-.--%

Duur

Periode

Stijl

Biotie Therapies : ACORDA GAINS TITLE TO BIOTIE SHARES AND THE SHARES WILL DELIST	30-09-16
Biotie Therapies : ARBITRAL TRIBUNAL CONFIRMED ACORDA'S REDEMPTION RIGHT REGARDING BIOTIE SHARES AND BIOTIE SHARES TRADING HAS BEEN TERMINATED	26-09-16
Biotie: BTT1023 receives Orphan Drug Designation in the United States	26-08-16
Biotie Therapies : THE LISTING COMMITTEE OF NASDAQ HELSINKI HAS RESOLVED TO DELIST THE SHARES OF BIOTIE THERAPIES CORP.	25-08-16
Biotie Therapies : CORP. APPLIES FOR DELISTING OF ITS SHARES FROM NASDAQ HELSINKI	18-08-16

Managers	Titel	Leeftijd	Van
Antero Kallio CEO	Chief Executive Officer	64	01-06-05

Besturend	Titel	Leeftijd	Van
Ronald Cohen CHM	Chairman	68	01-05-16
Jane Wasman BRD	Director/Board Member	67	01-05-16
Andrew Hindman BRD	Director/Board Member	51	01-12-16

Sector

	Vaira. 1 jan.	Kapi.
VERTEX PHARMACEUTICALS INCORPORATED	+8,29%	114 mld.
REGENERON PHARMACEUTICALS, INC.	+10,21%	104 mld.
ARGENX SE	0,00%	22,28 mld.
BIONTECH SE	-11,90%	22,41 mld.
GENMAB A/S	-4,55%	19,07 mld.
WUXI APPTEC CO., LTD.	-37,36%	18 mld.
BEIGENE, LTD.	-5,17%	17,89 mld.
NEUROCRINE BIOSCIENCES, INC.	+7,70%	14,28 mld.
SAREPTA THERAPEUTICS, INC.	+37,65%	12,55 mld.